![Scott Myers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Myers
Presidente presso
ZENTALIS PHARMACEUTICALS, INC.
Patrimonio netto: 2 M $ in data 31/07/2026
Profilo
Scott D.
Myers is currently Chairman at Convergent Therapeutics, Inc. and Chairman at Zentalis Pharmaceuticals, Inc., both positions starting in 2024.
Former roles include President & Chief Executive Officer at Aerocrine AB from 2011 to 2015; President, Chief Executive Officer & Director at Cascadian Therapeutics LLC from 2016 to 2018; Chairman & Chief Executive Officer at Rainier Therapeutics, Inc. from 2018 to 2020; President, Chief Executive Officer & Director at AMAG Pharmaceuticals, Inc. in 2020; President, Chief Executive Officer & Director at Viridian Therapeutics, Inc. in 2023; Chairman at Dynavax Technologies Corp.
from 2021 to 2026; Chairman at Sensorion SA from 2021 to 2023; Chairman at Harpoon Therapeutics, Inc. from 2021 to 2024; Chairman at Ironshore Therapeutics, Inc.; Independent Director at Trillium Therapeutics, Inc. in 2021; Independent Director at Orexo AB from 2012 to 2014; Independent Director at Selecta Biosciences, Inc. from 2019 to 2023; Director at Cartesian Therapeutics, Inc. in 2023; Senior Vice President-Marketing at DOV Pharmaceutical, Inc. from 2005 to 2007; and Vice President at UCB SA from 2007 to 2011.
Education includes undergraduate studies at Northwestern University and an MBA from The University of Chicago Booth School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 16/06/2026 | 395.895 ( 0,56% ) | 2 M $ | 31/07/2026 |
Posizioni attive di Scott Myers
| Società | Posizione | Inizio |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Presidente | 13/11/2024 |
Convergent Therapeutics, Inc.
 Convergent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapies for prostate cancer | Presidente | 01/03/2024 |
Precedenti posizioni note di Scott Myers
| Società | Posizione | Fine |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Presidente | 10/02/2026 |
| HARPOON THERAPEUTICS, INC. | Presidente | 11/03/2024 |
| VIRIDIAN THERAPEUTICS, INC. | Amministratore Delegato | 01/11/2023 |
| CARTESIAN THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/10/2023 |
Formazione di Scott Myers
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
58
Relazioni di 1° grado
18
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 18 |
|---|---|
Dynavax Technologies Corp.
 Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
DOV Pharmaceutical, Inc.
 DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops novel drugs | Commercial Services |
Aerocrine AB
 Aerocrine AB Electronic Equipment/InstrumentsElectronic Technology Manufactures and distributes medical devices for asthma patients | Electronic Technology |
Trillium Therapeutics, Inc.
 Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
Ironshore Therapeutics, Inc.
 Ironshore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and distributes central nervous system stimulant prescription medicines | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases | Health Technology |
UCB SA
 UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Orexo AB
 Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Sensorion SA
 Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders | Health Technology |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company developing a targeted biologic for the potential treatment of both early stage and metastatic bladder cancer | Health Technology |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
Viridian Therapeutics, Inc.
 Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Zentalis Pharmaceuticals, Inc.
 Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Convergent Therapeutics, Inc.
Convergent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapies for prostate cancer | Health Technology |
